Article Information
History
- March 29, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Yanan Zhao1,2,#,
- Annie Lee1,
- Kaelea Composto1,
- Marcus H. Cunningham1,
- Jose R. Mediavilla1,
- Samantha Fennessey3,
- André Corvelo3,
- Kar Fai Chow4,
- Michael Zody3,
- Liang Chen1,2,
- Barry N. Kreiswirth1,2,5 and
- David S. Perlin1,2,5,#
- 1Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ 07110, USA
- 2Hackensack Meridian School of Medicine, Nutley, NJ 07110, USA
- 3New York Genomic Center, NY 10013, USA
- 4Core Laboratory, Department of Pathology, Hackensack University Medical Center, Hackensack, NJ 07110, USA
- 5Georgetown University Lombardi Comprehensive Cancer Center, Washington, DC 20057, USA
- ↵#Address correspondence to Yanan Zhao, Ph.D. yanan.zhao{at}hmh-cdi.org, phone: 201-880-3503, or David S. Perlin, Ph.D. david.perlin{at}hmh-cdi.org, phone: 201-880-3500
Posted March 29, 2021.
A Novel Diagnostic Test to Screen SARS-CoV-2 Variants Containing E484K and N501Y Mutations
